Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Kidney cancer: where are we now, where are we going?

Michael Staehler, MD, PhD, Ludwig Maximilian University of Munich, Munich, Germany, gives his opinion on the key kidney cancer data from ASCO GU, highlighting combination therapy, immunotherapy and radiation. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.